|
⚲
|
| Keyboard |
| Emmens Matthew
✚
|
|
|---|---|
| CIK # | 0001298332 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001298332] | |
| 4 | [0001298332] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bristol Myers Squibb Co | |
| Emmens Matthew | |
| Vertex Pharmaceuticals Inc / Ma |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2021-03-31 | Grant | 574.21 | $63.13 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2021-02-01 | Grant | 3,054.17 | $62.21 | 190,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-12-31 | Grant | 584.40 | $62.03 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-09-30 | Grant | 601.26 | $60.29 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-06-30 | Grant | 616.50 | $58.80 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-03-31 | Grant | 650.34 | $55.74 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-02-01 | Grant | 3,018.27 | $62.95 | 190,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2019-12-31 | Grant | 564.73 | $64.19 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2019-09-30 | Grant | 714.85 | $50.71 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2019-06-30 | Grant | 767.54 | $45.35 | 34,808 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2019-03-31 | Grant | 681.20 | $47.71 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2019-02-01 | Grant | 3,708.16 | $49.89 | 185,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2018-12-31 | Grant | 625.24 | $51.98 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2018-09-30 | Grant | 523.52 | $62.08 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2018-06-30 | Grant | 587.28 | $55.34 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2018-03-31 | Grant | 513.83 | $63.25 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2018-02-01 | Grant | 2,945.86 | $62.80 | 185,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2017-12-31 | Grant | 530.35 | $61.28 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2017-09-30 | Grant | 509.88 | $63.74 | 32,500 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2017-06-30 | Grant | 537.42 | $55.72 | 29,945 |
| showing 20 of 29 most recent transactions | |||||